Latest filing published 18 Jun 2026 for Eupraxia Pharmaceuticals Inc.. Read the official filing
Alexander John Rothwell appears in our data through filings on Eupraxia Pharmaceuticals Inc. shares, published by SEDI. Over a trading history stretching from 15 December 2025 to 15 June 2026, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 18 June 2026 came the latest disclosure, a share grant in Eupraxia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations